SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)
Condition: AsthmaIntervention: Drug: MK0476, montelukast sodium / Duration of Treatment: 8 WeeksSponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials